Reynolds Blue
Patented Liposomal Formula
Advanced Technology
Revolutionary liposomal delivery system containing gold, silver, and silica. Each ½ ml serving delivers Over 15 quadrillion free electrons for enhanced ATP production.
Revolutionary liposomal delivery system containing gold, silver, and silica. Each ½ ml serving delivers Over 15 quadrillion free electrons for enhanced ATP production.
Reynolds Blue was conceptualized and developed by the scientist Mr. R.A. Reynolds before the onset of the COVID-19 pandemic. Produced in small batches, it underwent testing on ill volunteers from 2019 to 2022. All participants reported experiencing beneficial effects within 30 minutes, with the most rapid and significant improvements observed in those who were more severely weakened.
Nebulization of Reynolds Blue proved particularly effective for individuals infected with COVID-19, often resulting in a 5% to 10% increase in oxygen saturation levels in as little as 30 minutes. Sublingual and oral administration methods also demonstrated strong efficacy.
The formula for Reynolds Blue was refined multiple times to achieve optimal ratios of gold to silver atoms, alongside precise quantities of silica lattice and methylene blue relative to the gold, silver, and silica components.
Patents for this therapeutic were granted in the United States and Mexico in 2021 and 2022, respectively.
The company is presently pursuing funding to submit a New Drug Application (NDA) to the FDA and to register Reynolds Blue as a safe, over-the-counter medication. It is intended for the treatment and effective elimination of all upper respiratory viruses, with additional advantages including reactive oxygen species (ROS) scavenging and improved ATP production.
Over 15 quadrillion free electrons per ½ ml serving for enhanced ATP production
Advanced liposomal delivery system for maximum bioavailability
Patented formulation with proprietary technology protection
Supports cellular energy production at the mitochondrial level
Contains bioactive gold, silver, and silica in optimal ratios
Third-party tested for purity and potency
Proprietary formulation for enhanced absorption
Reynolds Blue is formulated from Methylene Blue, incorporated with gold and silver atoms within a silica lattice, all encapsulated in a liposomal structure. This design enables it to combat respiratory viruses, such as COVID-19 and influenza, in the nasal and throat passages while simultaneously enhancing cellular energy production.
Viruses in the Nasal and Throat Passages, Including COVID-19 and Influenza
Reynolds Blue optimizes Methylene Blue's efficacy by protecting it during delivery and targeting it directly to viral infection sites in the respiratory tract. The silica framework acts as a supportive matrix, while the gold and silver components generate localized energy surges to inhibit viral activity. The liposomal envelope improves adhesion and penetration into affected cells.
Preventing Viral Attachment
Reynolds Blue binds to the spike proteins on viruses like COVID-19 or influenza, blocking their ability to latch onto host cells. The integration of gold and silver amplifies this effect by harnessing electrochemical forces that disrupt these proteins, thereby halting viral entry and spread in the nasal and throat areas.
Disrupting Viral Genetic Material
Once inside infected cells, Reynolds Blue targets the virus's nucleic acids (DNA or RNA). Reynolds Blue induces oxidative stress through reactive oxygen species, and the gold-silver- silica complex accelerates this process, fragmenting the viral genome and preventing replication. This is particularly effective against viruses responsible for respiratory symptoms like colds, coughs, and sore throats.
Enhancing Cellular Energy Production by Improving Energy Transfer
Reynolds Blue boosts ATP synthesis—the primary energy currency of cells by facilitating electron transport in the mitochondria, the cell's energy hubs, to increase ATP output. The gold- silver-silica integration enhances this efficiency, accelerating the conversion of nutrients into usable energy.